• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Scarlett Gomez discusses prostate genomic testing in a world of precision medicine

Video

In this video, Scarlett Gomez, MD, PhD, discusses the background and findings of the study, “Active surveillance for watchful waiting in clinically low-risk prostate cancer patients in the SEER database with and without an Oncotype DX genomic prostate score assay,” presented at the 2021 American Urological Association Annual Meeting. Gomez is a professor in the department of epidemiology and biostatistics at the University of California, San Francisco.

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.